Correlation Between RenovoRx and Mineralys Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on RenovoRx and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Mineralys Therapeutics,.

Diversification Opportunities for RenovoRx and Mineralys Therapeutics,

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between RenovoRx and Mineralys is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of RenovoRx i.e., RenovoRx and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between RenovoRx and Mineralys Therapeutics,

Given the investment horizon of 90 days RenovoRx is expected to generate 0.79 times more return on investment than Mineralys Therapeutics,. However, RenovoRx is 1.26 times less risky than Mineralys Therapeutics,. It trades about 0.37 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.06 per unit of risk. If you would invest  98.00  in RenovoRx on August 29, 2024 and sell it today you would earn a total of  38.00  from holding RenovoRx or generate 38.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Mineralys Therapeutics, Common

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mineralys Therapeutics, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

RenovoRx and Mineralys Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Mineralys Therapeutics,

The main advantage of trading using opposite RenovoRx and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.
The idea behind RenovoRx and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk